Cubbon Richard M, Rajwani Adil, Wheatcroft Stephen B
The Academic Unit of Cardiovascular Medicine, The LIGHT Laboratories, University of Leeds, Clarendon Way, Leeds, UK.
Diab Vasc Dis Res. 2007 Jun;4(2):103-11. doi: 10.3132/dvdr.2007.027.
The structural and functional integrity of the vascular endothelium plays a critical role in vascular homeostasis. Insulin resistance, an important risk factor for cardiovascular disease, is thought to promote atherosclerosis through a reciprocal relationship with endothelial dysfunction. In health, cumulative damage to endothelial cells incurred by exposure to risk factors is mitigated by endogenous reparative processes. Disruption of the balance between endothelial damage and repair may mediate atherosclerotic progression. Bone marrow-derived 'endothelial progenitor cells' (EPC) have been identified as significant contributors to endogenous vascular repair. Insulin resistance is associated with a spectrum of biochemical abnormalities which have the potential to reduce the availability of EPCs and diminish their capacity for vascular repair. Many lifestyle and pharmacological interventions which improve insulin resistance also increase the numbers and functionality of EPCs. Cell-based therapies may also hold promise for the prevention and treatment of cardiovascular disease.
血管内皮的结构和功能完整性在血管稳态中起着关键作用。胰岛素抵抗是心血管疾病的一个重要危险因素,被认为通过与内皮功能障碍的相互关系促进动脉粥样硬化。在健康状态下,暴露于危险因素所导致的内皮细胞累积损伤可通过内源性修复过程得到缓解。内皮损伤与修复之间平衡的破坏可能介导动脉粥样硬化的进展。骨髓来源的“内皮祖细胞”(EPC)已被确定为内源性血管修复的重要贡献者。胰岛素抵抗与一系列生化异常有关,这些异常有可能减少EPC的可用性并削弱其血管修复能力。许多改善胰岛素抵抗的生活方式和药物干预措施也会增加EPC的数量和功能。基于细胞的疗法对心血管疾病的预防和治疗也可能具有前景。